152 results on '"Villani, P."'
Search Results
2. Pediatric torticollis: clinical report and predictors of urgency of 1409 cases
- Author
-
Raucci, Umberto, Roversi, Marco, Ferretti, Alessandro, Faccia, Valerio, Garone, Giacomo, Panetta, Fabio, Mariani, Carlo, Rizzotto, Eloisa, Torelli, Antonio, Colafati, Giovanna Stefania, Aulisa, Angelo Gabriele, Parisi, Pasquale, and Villani, Alberto
- Published
- 2024
- Full Text
- View/download PDF
3. Epidemiology of respiratory syncytial virus in a large pediatric hospital in Central Italy and development of a forecasting model to predict the seasonal peak
- Author
-
Cutrera, Renato, Ciofi degli Atti, Marta Luisa, Dotta, Andrea, D’Amore, Carmen, Ravà, Lucilla, Perno, Carlo Federico, and Villani, Alberto
- Published
- 2024
- Full Text
- View/download PDF
4. Pediatric acute hospitalization for anorexia nervosa: an economic evaluation
- Author
-
Marchili, Maria Rosaria, Bozzola, Elena, Guolo, Stefano, Marchesani, Silvio, Spina, Giulia, Mascolo, Cristina, Vicari, Stefano, De Jacobis, Isabella Tarissi, Raponi, Massimiliano, and Villani, Alberto
- Published
- 2024
- Full Text
- View/download PDF
5. Pediatric ultrasound practice in Italy: an exploratory survey
- Author
-
Anna Maria Musolino, Monica Tei, Cristina De Rose, Danilo Buonsenso, Maria Chiara Supino, Stefania Zampogna, Annamaria Staiano, Massimiliano Raponi, Antonella Amendolea, Vincenzo Colacino, Laura Gori, Alessandro Manganaro, Riccardo Ricci, Victoria D’Inzeo, Salvatore Grosso, Alberto Villani, and Rino Agostiniani
- Subjects
Pediatric ultrasound ,Education ,Training ,Pediatric residency ,Point-of-care ultrasound ,Survey ,Pediatrics ,RJ1-570 - Abstract
Abstract Background The aim of this exploratory survey is to describe the current state of US (ultrasound) technique across different pediatric settings nationwide. Methods A questionnaire was emailed to all members of the Italian Society of Pediatrics, including pediatric residents. The survey was open from December 2021 to March 2022. Results There were 1098 respondents. Seven hundred and seven pediatricians (84.1%) reported any use of US, while 51 (44.3%) residents denied it. The majority of participants (n = 956, 87.1%) reported to have a US machine available within the department, mostly cart-based (n = 516, 66.9%) and provided from 1 to 5 years prior to the survey (n = 330, 42.8%). Lung and neonatal cerebral regions were the most frequently scanned (n = 289, 18.7% and n = 218, 14.1%, respectively). The suspicion of pneumonia or respiratory distress represented the main reasons for performing US in emergency room (n = 390, 78% and n = 330, 66%, respectively). The majority of family pediatricians reported to scan lung and kidney/urinary tract regions (n = 30, 16.9%, and n = 23,12.9%, respectively). Regarding US training, the majority of respondents (n = 358, 34.6%) declared an experience-based education, with a deficient certification enabling the use of US in 71.6% (n = 552) of cases. The most common barriers included the lack of a well-defined training program (n = 627, 57.1%), unavailability of the US machine (n = 196, 17.9%) and legal responsibility concern (n = 175, 15.9%). Conclusions Despite the growing interest on pediatric US nationally, significant barriers still limit widespread adoption. These obstacles may be addressed through the dissemination of a specific US education plan and providing additional resources.
- Published
- 2024
- Full Text
- View/download PDF
6. Pediatric torticollis: clinical report and predictors of urgency of 1409 cases
- Author
-
Umberto Raucci, Marco Roversi, Alessandro Ferretti, Valerio Faccia, Giacomo Garone, Fabio Panetta, Carlo Mariani, Eloisa Rizzotto, Antonio Torelli, Giovanna Stefania Colafati, Angelo Gabriele Aulisa, Pasquale Parisi, and Alberto Villani
- Subjects
Torticollis ,Emergency ,Children ,Pediatrics, Neck complaints ,Pediatrics ,RJ1-570 - Abstract
Abstract Background To date, the etiology and risk factors of torticollis are still poorly defined in the pediatric literature. Especially in the Emergency Department (ED) scenario, it is critical to reliably distinguish benign and transient conditions from (potentially) life-threatening disorders. This study describes the clinical characteristics of a large sample of children with torticollis. The aim of our study was to detect epidemiology, etiology and predictive variables associated with a higher risk of life-threatening conditions in acute torticollis. Methods We conducted a pediatric retrospective study of acute torticollis over a 13-year period referred to the ED of a tertiary pediatric Hospital. We reported the characteristics in the overall sample and in two subgroups divided according to urgency of the underlying condition. Furthermore, we developed a multivariate model aimed at identifying the main clinical predictors of the need for urgent care. Results 1409 patients were analyzed (median age 5.7 years, IQR 5.8). A history of trauma was present in 393 patients (27.9%). The symptom most frequently associated with torticollis were pain (83.5%). At least one pathological finding was found in 5.4 to 7.9% of patients undergoing further imaging. Hospitalization was required in 11.1% of cases (median duration 4 days). The most frequent etiologies of torticollis were postural cause (43.1%), traumatic (29.5%), and infective/inflammatory (19.1%). A longer time from onset of torticollis and the presence of headache or vomiting were strongly correlated with an underlying urgent condition, after adjusting for the other clinically and statistically significant variables in the bivariate analysis. Conclusion Our study shows that an urgent condition most commonly occur in patients presenting with history of trauma or headache, vomiting and torticollis for more than 24 h should undergo further diagnostic evaluation and short-term follow-up, restricting invasive or expensive investigations to patients with clinical suspicion of an underlying harmful condition.
- Published
- 2024
- Full Text
- View/download PDF
7. Epidemiology of respiratory syncytial virus in a large pediatric hospital in Central Italy and development of a forecasting model to predict the seasonal peak
- Author
-
Renato Cutrera, Marta Luisa Ciofi degli Atti, Andrea Dotta, Carmen D’Amore, Lucilla Ravà, Carlo Federico Perno, and Alberto Villani
- Subjects
Respiratory Syncytial Virus ,Children ,SARIMA ,Epidemiology ,Hospitalization ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Respiratory Syncytial Virus (RSV) is responsible for the majority of acute lower respiratory infections in infants and can affect also older age groups. Restrictions linked to the emergence of the SARS-CoV-2 pandemic and their subsequent lifting caused a change in the dynamics of RSV circulation. It is therefore fundamental to monitor RSV seasonal trends and to be able to predict its seasonal peak to be prepared to the next RSV epidemics. Methods We performed a retrospective descriptive study on laboratory-confirmed RSV infections from Bambino Gesù Children’s Hospital in Rome from 1st January 2018 to 31st December 2022. Data on RSV-positive respiratory samples (n = 3,536) and RSV-confirmed hospitalizations (n = 1,895) on patients aged 0–18 years were analyzed. In addition to this, a SARIMA (Seasonal AutoRegressive Integrated Moving Average) forecasting model was developed to predict the next peak of RSV. Results Findings show that, after the 2020 SARS-CoV-2 pandemic season, where RSV circulation was almost absent, RSV infections presented with an increased and anticipated peak compared to pre-pandemic seasons. While mostly targeting infants below 1 year of age, there was a proportional increase in RSV infections and hospitalizations in older age groups in the post-pandemic period. A forecasting model built using RSV weekly data from 2018 to 2022 predicted the RSV peaks of 2023, showing a reasonable level of accuracy (MAPE 33%). Additional analysis indicated that the peak of RSV cases is expected to be reached after 4–5 weeks from case doubling. Conclusion Our study provides epidemiological evidence on the dynamics of RSV circulation before and after the COVID-19 pandemic. Our findings highlight the potential of combining surveillance and forecasting to promote preparedness for the next RSV epidemics.
- Published
- 2024
- Full Text
- View/download PDF
8. Pediatric acute hospitalization for anorexia nervosa: an economic evaluation
- Author
-
Maria Rosaria Marchili, Elena Bozzola, Stefano Guolo, Silvio Marchesani, Giulia Spina, Cristina Mascolo, Stefano Vicari, Isabella Tarissi De Jacobis, Massimiliano Raponi, and Alberto Villani
- Subjects
Anorexia nervosa ,Hospitalization ,Hospitalization acute cost ,Children ,Covid-19 ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Anorexia nervosa (AN) is a psychiatric disorders which may potentially led to a high risk of health medical complications, suicide and self-harming behaviour. Since Covid-19 pandemic onset in March 2020, evidence suggested an increase occurrence of AN. The main aim of the retrospective analysis is to define the cost of hospitalization in the acute phase (HAP) at IRCCS Bambino Gesù Children Hospital, Rome, Italy, over 2 years study. Secondary purposes are defining the main risk factors for a prolonged hospitalization (including age, sex and comorbidities) and the possible influence of Covid-19 pandemic on AN admission and hospital stay. Methods for the purpose of the study, we included children and adolescents aged less than 18 years, admitted to IRCCS Bambino Gesù Children Hospital, Rome, Italy, with a diagnosis of AN. Medical costs were calculated consulting the Lazio Regional Health Service Tariffs. Basing on the date of hospital admission, patients were later divided into two subgroups: subgroup A included patients hospitalized prior than Covid-19 onset (from March 2019 to February 2020) and subgroup B those admitted after (from March 2020 to October 2022). Results a total of 260 patients has been included in the study with a median age of 15 years (range 6–18 years). The total health care cost of AN hospitalized patients was of EUR 3,352,333 with a median cost of EUR 11,124 for each admission (range EUR 930 − 45,739) and a median daily cost of EUR 593 (range EUR 557–930). Median cost was higher in case of comorbidities, guarded patients, enteral feeding. A prolonged hospitalization has been documented in subgroup A with a higher economic burden. Conclusions the economic burden of eating disorders is of note. Adequate sanitary policies as well as health economic analyses are required to gain insight into the cost-effectiveness of AN management. Trial registration 2526-OPBG-2021.
- Published
- 2024
- Full Text
- View/download PDF
9. Human parechovirus meningitis in children: state of the art
- Author
-
Bozzola, Elena, Barni, Sarah, Barone, Chiara, Perno, Carlo Federico, Maggioni, Andrea, and Villani, Alberto
- Published
- 2023
- Full Text
- View/download PDF
10. Accuracy of Pancreatic Stone Protein for diagnosis of sepsis in children admitted to pediatric intensive care or high-dependency care: a pilot study
- Author
-
Bottari, Gabriella, Caruso, Mariangela, Paionni, Emanuel, De Luca, Maia, Romani, Lorenza, Pisani, Mara, Grandin, Annalisa, Gargiullo, Livia, Zampini, Giorgio, Gagliardi, Chiara, Fegatelli, Danilo Alunni, Vestri, Annarita, Lancella, Laura, Porzio, Ottavia, Muda, Andrea Onetti, Villani, Alberto, Atti, Marta Ciofi Degli, Raponi, Massimiliano, and Cecchetti, Corrado
- Published
- 2023
- Full Text
- View/download PDF
11. Bronchiolitis guidelines: what about the Italian situation in a primary care setting?
- Author
-
Porcaro, Federica, Cutrera, Renato, Vittucci, Anna Chiara, and Villani, Alberto
- Published
- 2023
- Full Text
- View/download PDF
12. Influenza viruses circulation in a tertiary care children hospital in Rome: a comparison between 2022 and the previous 5 years
- Author
-
Ranno, Stefania, Coltella, Luana, Linardos, Giulia, Di Maio, Velia Chiara, Colagrossi, Luna, Gentile, Leonarda, Galeno, Eugenia, Ciofi degli Atti, Marta Luisa, Cristaldi, Sebastian, Villani, Alberto, Raponi, Massimiliano, Perno, Carlo Federico, and Russo, Cristina
- Published
- 2023
- Full Text
- View/download PDF
13. The impact of the COVID-19 pandemic on eating disorders risk and symptoms: a retrospective study
- Author
-
Straface, Elisabetta, Jacobis, Isabella Tarissi De, Capriati, Teresa, Pretelli, Italo, Grandin, Annalisa, Mascolo, Cristina, Vona, Rosa, Gambardella, Lucrezia, Cittadini, Camilla, Villani, Alberto, and Marchili, Maria Rosaria
- Published
- 2023
- Full Text
- View/download PDF
14. Paraneoplastic pemphigus and Castleman’s disease: a case report and a revision of the literature
- Author
-
Irrera, Mariangela, Bozzola, Elena, Cardoni, Antonello, DeVito, Rita, Diociaiuti, Andrea, El Hachem, Maya, Girardi, Katia, Marchesi, Alessandra, and Villani, Alberto
- Published
- 2023
- Full Text
- View/download PDF
15. Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy
- Author
-
Marano, Marco, Roversi, Marco, Severini, Flavia, Memoli, Claudia, Musolino, Antonio, Pisani, Mara, Cecchetti, Corrado, and Villani, Alberto
- Published
- 2023
- Full Text
- View/download PDF
16. Aggregatibacter actinomycetemcomitans infection in a 15-year-old boy with pulmonary empyema: a case report and review of literature
- Author
-
Mesturino, Maria Alessia, Bitetti, Carol, Clemente, Anna, Krzysztofiak, Andrzej, Lancella, Laura, Lombardi, Roberta, Cursi, Laura, Boccuzzi, Elena, Musolino, Anna Maria, and Villani, Alberto
- Published
- 2023
- Full Text
- View/download PDF
17. Human parechovirus meningitis in children: state of the art
- Author
-
Elena Bozzola, Sarah Barni, Chiara Barone, Carlo Federico Perno, Andrea Maggioni, and Alberto Villani
- Subjects
Human parechovirus ,Children ,Meningitis ,Central nervous system Infection ,Pediatrics ,RJ1-570 - Abstract
Abstract Human Parechovirus is a common cause of infection occurring especially during the first years of life. It may present with a broad spectrum of manifestations, ranging from a pauci-symptomatic infection to a sepsis-like or central nervous system disease. Aim of this study is to explore the knowledge on Parechovirus meningitis. According to the purpose of the study, a systematic review of the literature focusing on reports on central nervous system. Parechovirus infection of children was performed following PRISMA criteria. Out of the search, 304 papers were identified and 81 records were included in the revision dealing with epidemiology, clinical manifestations, laboratory findings, imaging, therapy and outcome. Parechovirus meningitis incidence may vary all over the world and outbreaks may occur. Fever is the most common symptom, followed by other non-specific signs and symptoms including irritability, poor feeding, skin rash or seizures. Although several reports describe favourable short-term neurodevelopmental outcomes at discharge after Parechovirus central nervous system infection, a specific follow up and the awareness on the risk of sequelae should be underlined in relation to the reported negative outcome. Evidence seems to suggest a correlation between magnetic imaging resonance alteration and a poor outcome.
- Published
- 2023
- Full Text
- View/download PDF
18. Accuracy of Pancreatic Stone Protein for diagnosis of sepsis in children admitted to pediatric intensive care or high-dependency care: a pilot study
- Author
-
Gabriella Bottari, Mariangela Caruso, Emanuel Paionni, Maia De Luca, Lorenza Romani, Mara Pisani, Annalisa Grandin, Livia Gargiullo, Giorgio Zampini, Chiara Gagliardi, Danilo Alunni Fegatelli, Annarita Vestri, Laura Lancella, Ottavia Porzio, Andrea Onetti Muda, Alberto Villani, Marta Ciofi Degli Atti, Massimiliano Raponi, and Corrado Cecchetti
- Subjects
Biomarkers ,Pediatric Sepsis ,Pediatric Septic shock ,Procalcitonin ,C-Reactive protein ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Pancreatic Stone Protein (PSP) is one of the most promising diagnostic and prognostic markers. The aim of the study was to assess the accuracy of PSP, compared to C-Reactive Protein (CRP), and Procalcitonin (PCT) for sepsis diagnosis in pediatric patients. Furthermore, we explored the correlation of PSP levels with sepsis severity and organ failure measured with PELOD-2 score. Methods Forty pediatric patients were enrolled following admission to pediatric intensive care, high dependency care or pediatric ward. PSP blood levels were measured in Emergency Department (nanofluidic point-of-care immunoassay; abioSCOPE, Abionic SA, Switzerland) on day 1, 2, 3, 5 and 7 from the onset of the clinical signs and symptoms of sepsis or SIRS. Inclusion criteria were: 1) patient age (1 month to 18 years old), 2) signs and symptoms of SIRS, irrespective of association with organ dysfunction. Exclusion criteria were: 1) hemato-oncological diseases and/or immunodeficiencies, 2) pancreatic diseases. Results Septic patients showed higher PSP levels than those with non-infectious systemic inflammation. The optimal cut-off in diagnosis of sepsis for PSP at day 1 was 167 ng/ml resulted in a sensitivity of 59% (95% IC 36%—79%) and a specificity of 83% (95% IC 58%-96%) with an AUC of 0.636 for PSP in comparison to AUC of 0.722 for PCT and 0.503 for C-RP. ROC analysis for outcome (survival versus no survival) has showed AUC 0.814 for PSP; AUC 0.814 for PCT; AUC of 0.657 for C-RP. Conclusions PSP could distinguish sepsis from non-infectious systemic inflammation; however, our results need to be confirmed in larger pediatric population.
- Published
- 2023
- Full Text
- View/download PDF
19. Bronchiolitis guidelines: what about the Italian situation in a primary care setting?
- Author
-
Federica Porcaro, Renato Cutrera, Anna Chiara Vittucci, and Alberto Villani
- Subjects
Acute viral bronchiolitis ,Guidelines ,Management ,Outpatient setting ,Pediatrics ,RJ1-570 - Abstract
Abstract Acute viral bronchiolitis is the most common cause of hospitalization in children under 12 months of age. The variable clinical presentation and the potential for sudden deterioration of the clinical conditions require a close monitoring by healthcare professionals. In Italy, first access care for children is provided by primary care physicians (PCPs) who often must face to a heterogeneous disease presentation that, in some cases, make the management of patient with bronchiolitis challenging. Consequently, Italian studies report poor adherence to national and international guidelines processed to guide the clinicians in decision making in acute viral bronchiolitis. This paper aims to identify the potential factors contributing to the lack of adherence to the suggested guidelines derived by clear and evidence-based recommendations among primary care physicians operating in an outpatient setting, with a specific focus on the context of Italy. Particularly, we focus on the prescription of medications such as β2-agonists, systemic steroids, and antibiotics which are commonly prescribed by PCPs to address conditions that can mimic bronchiolitis.
- Published
- 2023
- Full Text
- View/download PDF
20. Influenza viruses circulation in a tertiary care children hospital in Rome: a comparison between 2022 and the previous 5 years
- Author
-
Stefania Ranno, Luana Coltella, Giulia Linardos, Velia Chiara Di Maio, Luna Colagrossi, Leonarda Gentile, Eugenia Galeno, Marta Luisa Ciofi degli Atti, Sebastian Cristaldi, Alberto Villani, Massimiliano Raponi, Carlo Federico Perno, and Cristina Russo
- Subjects
Influenza ,Year-round surveillance ,Pediatric ,Influenza-like Illness ,Seasonality ,Out-of-season circulation ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Influenza surveillance aims to determine onset, duration and intensity of the seasonal Influence-like Illness (ILI); data collection begins in the week 42 of a year and ends in the week 17 of the following year. In this observational study, we report the experience of a tertiary care children hospital in Rome about Influenza viruses circulation during the calendar year 2022 (January-December) in comparison with the previous five years (2017–2021), with a special focus on the weeks 18–41, usually not under surveillance. Methods This retrospective study involved 36782 respiratory samples referred to 21354 patients (pts), median age 2.63 years, admitted with respiratory symptoms at Bambino Gesù Children’s Hospital in the years 2017–2022. Respiratory viruses were detected by molecular Allplex™ Respiratory Panel Assays (Seegene, Korea). Results Regarding the pre pandemic years, 2017–2019, distribution of Flu positive patients focused in the first weeks of the year (weeks 1–17). During the pandemic period, Flu was not detected. In 2022, 239 Flu viruses were identified: 37 FluA (weeks 1–17), 29 FluA (weeks 18–41) and 168 FluA and 5 FluB (weeks 42–52). For the year 2022, during the non-epidemic period, the number of Flu viruses detected corresponded to 12.1% of total Flu detected, respect to 0-1.7% for the previous five years (p
- Published
- 2023
- Full Text
- View/download PDF
21. Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)
- Author
-
Galli, Elena, Fortina, Anna Belloni, Ricci, Giampaolo, Maiello, Nunzia, Neri, Iria, Baldo, Ermanno, Berti, Irene, Bonamonte, Domenico, Capra, Lucetta, Carboni, Elena, Carello, Rossella, Caroppo, Francesca, Cavagni, Giovanni, Chinellato, Iolanda, Cipriani, Francesca, Comberiati, Pasquale, Diociaiuti, Andrea, Di Lernia, Vito, Duse, Marzia, Filippeschi, Cesare, Giannetti, Arianna, Giovannini, Mattia, Licari, Amelia, Marseglia, Gian Luigi, Pace, Manuela, Patrizi, Annalisa, Pajno, Giovanni Battista, Peroni, Diego, Villani, Alberto, and Eichenfield, Lawrence
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Pediatric ,Pediatric Research Initiative ,Good Health and Well Being ,Adolescent ,Child ,Dermatitis ,Atopic ,Dermatology ,Humans ,Hyperplasia ,Pediatricians ,Pediatrics ,Atopic Dermatitis ,Childhood ,Position Paper ,Management ,Topical Therapies ,New Drugs ,Paediatrics and Reproductive Medicine ,Paediatrics - Abstract
Currently, there are a few detailed guidelines on the overall management of children and adolescents with moderate-severe atopic dermatitis. AD is a complex disease presenting with different clinical phenotypes, which require an individualized and multidisciplinary approach. Therefore, appropriate interaction between primary care pediatricians, pediatric allergists, and pediatric dermatologists is crucial to finding the best management strategy. In this manuscript, members of the Italian Society of Pediatric Allergology and Immunology (SIAIP), the Italian Society of Pediatric Dermatology (SIDerP), and the Italian Society of Pediatrics (SIP) with expertise in the management of moderate-severe atopic dermatitis have reviewed the latest scientific evidence in the field. This narrative review aims to define a pathway to appropriately managing children and adolescents with moderate-severe atopic dermatitis.
- Published
- 2022
22. The impact of the COVID-19 pandemic on eating disorders risk and symptoms: a retrospective study
- Author
-
Elisabetta Straface, Isabella Tarissi De Jacobis, Teresa Capriati, Italo Pretelli, Annalisa Grandin, Cristina Mascolo, Rosa Vona, Lucrezia Gambardella, Camilla Cittadini, Alberto Villani, and Maria Rosaria Marchili
- Subjects
Covid-19 ,Pandemic ,Eating disorders ,Comorbidity ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Social distancing and quarantine imposed by the authority during the COVID-19 pandemic caused restrictions, which had a negative impact on eating behavior, especially among adolescents. We proposed a retrospective study aimed to evaluate the effect of the COVID-19 pandemic on eating disorders risk and symptoms. Methods In this study, a group of 127 pediatric patients (117 females and 10 males) with eating disorders admitted to the Bambino Gesù Children’s Hospital of Rome (Italy), in the period between August 2019 and April 2021, was analyzed. All patient data were collected from patients’ electronic medical records. Results We found that 80.3% of patients were at the onset of eating disorders and that 26% of patients had familiarity for psychotic disorders. Often these patients had comorbidities and alterations in blood parameters such as leukocytopenia, neutropenia, hypovitaminosis and hormonal problems that could affect their future. Conclusions Our findings could provide a framework for developing clinical and educational interventions to mitigate the short- and long-term negative impact of the pandemic on adolescent future health.
- Published
- 2023
- Full Text
- View/download PDF
23. Aggregatibacter actinomycetemcomitans infection in a 15-year-old boy with pulmonary empyema: a case report and review of literature
- Author
-
Maria Alessia Mesturino, Carol Bitetti, Anna Clemente, Andrzej Krzysztofiak, Laura Lancella, Roberta Lombardi, Laura Cursi, Elena Boccuzzi, Anna Maria Musolino, and Alberto Villani
- Subjects
Aggregatibacter actinomycetemcomitans ,HACEK ,Pulmonary empyema ,Chest wall abscess ,Drainage fluid culture ,Antimicrobial therapy ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Aggregatibacter actinomycetemcomitans (Aa), previously known as Actinobacillus actinomycetemcomitans, is a slow-growing Gram-negative coccobacillus, member of the HACEK group of bacteria colonizing oral flora. Besides causing infectious diseases in the oral cavity such as dental caries and periodontitis, it is responsible for severe extra-oral infections secondary to hematogenous spread or aspiration, such as endocarditis, soft tissue abscesses and osteomyelitis. The diagnosis depends on prolonged bacterial culture of biological material obtained through biopsy. Aa is susceptible to most antibiotics but complete eradication often requires a long term treatment. Case presentation We report the case of a 15-year-old previously healthy boy diagnosed with both pulmonary empyema and subphrenic chest wall abscess caused by Aa. He was admitted to our Pediatric Emergency department for evaluation of a right mass associated with marked asthenia and dry cough. After radiological findings etiological diagnosis was made by culture of fluid drainage of pleural empyema. He started empirical antibiotic therapy with intravenous piperacillin/tazobactam, whose sensibility was confirmed by the antibiogram, then, for occurrance of hepatopathy it was switched to ciprofloxacin: the patient almost completely recovered after 6-month therapy. Conclusions Extra-oral infections caused by Aa are extremely rare, especially in children, and not well described yet. To our knowledge, there is only another similar case described in literature. However, the case described in our manuscript represents the only one presenting with pulmonary empyema without involvement of lung parenchyma in children. We also conducted a brief review of published cases of Aa infection in the pediatric population. This case report reminds us the importance of an accurate inspection of the oral cavity during the examination of pediatric patients.
- Published
- 2023
- Full Text
- View/download PDF
24. Paraneoplastic pemphigus and Castleman’s disease: a case report and a revision of the literature
- Author
-
Mariangela Irrera, Elena Bozzola, Antonello Cardoni, Rita DeVito, Andrea Diociaiuti, Maya El Hachem, Katia Girardi, Alessandra Marchesi, and Alberto Villani
- Subjects
Paraneoplastic pemphigus ,Castelman’s disease ,Child ,Therapy ,Case report ,Pediatrics ,RJ1-570 - Abstract
Abstract Background In literature, a few reports described an association between paraneoplastic pemphigus (PNP) and Castelman’s disease (CD), but no consensus have been proposed for the diagnostic-therapeutical approach. Aim of this study is to present a case report and explore the relationship between PNP and CD in pediatric patients, focusing on clinical manifestations, histopathological findings, treatment and outcome to find elements for an early diagnosis. Case presentation We present the clinical case of a 13 years old girl with a challenging diagnosis of PNP and CD who underwent therapy at first with Rituximab and then with Siltuximab, for the control of symptoms. Conclusions Reviewing literature, 20 clinical cases have been described in the pediatric age. Diagnosis may be challenging, requiring an average of 3 months (range from 3 weeks to 2 years). In all cases, the initial manifestations were mucocutaneous lesions, especially oral lesions with poor response to conventional treatment. Systemic symptoms may be present as well. Therapeutical approach is still discussed with no consensus. Almost all patients received corticosteroids with poor response. Other drugs including azathioprine, methotrexate, cyclosporine and monoclonal antibodies have been evaluated for the control of the disease. Further studies and experimental trials urge to define the diagnostic criteria and therapy protocol.
- Published
- 2023
- Full Text
- View/download PDF
25. Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy
- Author
-
Marco Marano, Marco Roversi, Flavia Severini, Claudia Memoli, Antonio Musolino, Mara Pisani, Corrado Cecchetti, and Alberto Villani
- Subjects
Pediatric poisoning ,Antipyretics ,Analgesics ,Non-steroidal anti-inflammatory drugs ,Paracetamol ,Acetaminophen ,Pediatrics ,RJ1-570 - Abstract
Abstract Background This study aimed to analyze all the patients who contacted the hospital’s pediatric poison control center (PPCC) for exposure to ibuprofen and acetaminophen, in order to assess the incidence of any adverse reactions. Methods We retrospectively reported the clinical data of children who accessed the PPCC of the Bambino Gesù Children’s Hospital, IRCCS, Rome, from January 1, 2018 to September 30, 2022 due to wrong, accidental or intentional intake of inappropriate doses of acetaminophen and/or ibuprofen. In addition, we compared patients according to the intake of one of the two drugs and reported the trimestral distribution of cases during the study period. Results A total of 351 patients accessed the PPCC during the study period. The median age was 3.0 years. Most patients were females (57.8%). The most common reason for inappropriate oral intake of paracetamol or ibuprofen was a wrong use or an accidental intake (78.6%), with a fifth of patients taking the drug with suicidal intent (21.1%). According to the PPCC evaluation, most patients were not intoxicated (70.4%). Hospitalization was required for 30.5% of patients. Adverse reactions were reported in 10.5% of cases, with a similar incidence in patients who took paracetamol or ibuprofen. Nausea and vomiting were the most commonly reported adverse reactions. A higher frequency of moderate intoxication was found in patients who took paracetamol compared to ibuprofen (p = 0.001). The likelihood of intoxication was also higher in the paracetamol cohort. A spike of cases was registered at the end of 2021. Conclusions We analyze exposures to the two most commonly used pediatric molecules, paracetamol and ibuprofen, to assess the frequency of adverse reactions. We demonstrated that these relatively “safe” drugs may be associated with intoxications and adverse reactions when inappropriately administered.
- Published
- 2023
- Full Text
- View/download PDF
26. Children at risk of domestic accidents when are locked up at home: the other side of COVID-19 outbreak lockdown
- Author
-
Valentina Ferro, Raffaella Nacca, Mara Pisani, Sebastian Cristaldi, Maria Francesca Faa, Maria Chiara Supino, Umberto Raucci, Antonino Reale, Marta Ciofi Degli Atti, Massimiliano Raponi, Alberto Villani, and Anna Maria Musolino
- Subjects
Home accidents ,COVID-19 ,Lockdown ,Children ,Emergency ,Pediatrics ,RJ1-570 - Abstract
Abstract Background We proposed to analyze thoroughly the impact of the COVID-19 lockdown (CL) in changes of profiles and in trend of the domestic accidents (DAs) in children. Methods This was a single experience, cross-sectional study conducted at the emergency department (ED) of III trauma center. We enrolled children under 18 years admitted to ED with a diagnosis of DAs comparing the CL period from 10th March 2020 to 4th May 2020 with the same period of the previous year,10th March 2019 to 4th May 2019. Results In CL period, the cumulative incidence of ED visits for DAs increased from 86.88 to 272.13 per 1,000 children and the cumulative incidence of hospitalizations for DAs increased from 409.72 to 534.48 per 1,000 children. We reported in CL a decrease in the severity of ED presentation assessed by proxy measures: the level of priority ED visits reduced by 67% in CL period (OR: 0.33; 95%CI 0.22–0.48; p
- Published
- 2022
- Full Text
- View/download PDF
27. The pandemic within the pandemic: the surge of neuropsychological disorders in Italian children during the COVID-19 era
- Author
-
Elena Bozzola, Pietro Ferrara, Giulia Spina, Alberto Villani, Marco Roversi, Massimiliano Raponi, Giovanni Corsello, Annamaria Staiano, and the Italian Pediatric COVID-19 Board
- Subjects
COVID19 ,Neuropsychological disorders ,Children ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Quarantine and isolation measures during COVID-19 pandemic may have caused additional stress and challenged the mental health of the youth. Aim of the study is to investigate the COVID-19 pandemic impact on neuropsychological disorders (NPD) of Italian children and adolescents to provide general pediatric recommendations. Material and methods A retrospective multicenter observational study was planned by the Italian Pediatric Society (SIP) to explore the impact of COVID-19 on the access of children to pediatric Emergency Departments (pED) for the evaluation of neuropsychological symptoms, collecting the classification codes of diagnoses between March 1, 2019 and March 2, 2021. The period study was split into two sub-periods: a pre COVID-19 period (from March 1 2019 to March 1, 2020) and a COVID-19 period (from March 2, 2020 to March 2, 2021). As additional information, data on NPD hospitalizations in any pediatric department of the involved centers were recorded. Results During the study period, a total of 533,318 children were admitted to the pED involved in the study. Despite a 48.2% decline of pED admissions, there was a significant increase (83.1%) in patient admissions for NPD. The most frequent NPD conditions which increased during the COVID-19 pandemic were suicidal ideation (+ 147%), depression (+ 115%), eating disorder (+ 78.4%), and psychosis (+ 17.2%). During the pandemic period, a 39.5% increase in NPD hospitalizations was observed as well. The NPD disorders that mostly required hospitalizations were suicidal ideation (+ 134%), depression (+ 41.4%), eating disorder (+ 31.4%), and drug abuse (+ 26.7%). COVID-19 pandemic had a major impact on children's health, mainly on their NPD development. Neuropsychological assessment should be required at the primary level, in the pediatrician's office, to facilitate early capture of the sign of impairment and provide an adequate treatment. Conclusion SIP underlines the psychological consequences of COVID 19 pandemic on the youngest and recommends an early identification of NPD in the pediatric population to avoid other serious consequences for children's physical and mental health.
- Published
- 2022
- Full Text
- View/download PDF
28. Alert sign and symptoms for the early diagnosis of pulmonary tuberculosis: analysis of patients followed by a tertiary pediatric hospital
- Author
-
Elisa Farina, Carmen D’Amore, Laura Lancella, Elena Boccuzzi, Marta Luisa Ciofi degli Atti, Antonino Reale, Paolo Rossi, Alberto Villani, Massimiliano Raponi, and Umberto Raucci
- Subjects
Children ,Tuberculosis ,Early diagnosis ,Emergency ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Intercepting earlier suspected TB (Tuberculosis) cases clinically is necessary to reduce TB incidence, so we described signs and symptoms of retrospective cases of pulmonary TB and tried to evaluate which could be early warning signs. Methods We conducted a retrospective descriptive study of pulmonary TB cases in children in years 2005–2017; in years 2018–2020 we conducted a cohort prospective study enrolling patients
- Published
- 2022
- Full Text
- View/download PDF
29. Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)
- Author
-
Elena Galli, Anna Belloni Fortina, Giampaolo Ricci, Nunzia Maiello, Iria Neri, Ermanno Baldo, Irene Berti, Domenico Bonamonte, Lucetta Capra, Elena Carboni, Rossella Carello, Francesca Caroppo, Giovanni Cavagni, Iolanda Chinellato, Francesca Cipriani, Pasquale Comberiati, Andrea Diociaiuti, Vito Di Lernia, Marzia Duse, Cesare Filippeschi, Arianna Giannetti, Mattia Giovannini, Amelia Licari, Gian Luigi Marseglia, Manuela Pace, Annalisa Patrizi, Giovanni Battista Pajno, Diego Peroni, Alberto Villani, and Lawrence Eichenfield
- Subjects
Atopic Dermatitis ,Childhood ,Position Paper ,Management ,Topical Therapies ,New Drugs ,Pediatrics ,RJ1-570 - Abstract
Abstract Currently, there are a few detailed guidelines on the overall management of children and adolescents with moderate-severe atopic dermatitis. AD is a complex disease presenting with different clinical phenotypes, which require an individualized and multidisciplinary approach. Therefore, appropriate interaction between primary care pediatricians, pediatric allergists, and pediatric dermatologists is crucial to finding the best management strategy. In this manuscript, members of the Italian Society of Pediatric Allergology and Immunology (SIAIP), the Italian Society of Pediatric Dermatology (SIDerP), and the Italian Society of Pediatrics (SIP) with expertise in the management of moderate-severe atopic dermatitis have reviewed the latest scientific evidence in the field. This narrative review aims to define a pathway to appropriately managing children and adolescents with moderate-severe atopic dermatitis.
- Published
- 2022
- Full Text
- View/download PDF
30. Incidental pineal gland cyst in girls with early onset of puberty
- Author
-
Filippo, Gianpaolo De, Gaudino, Rossella, Calcaterra, Valeria, Villani, Alberto, Bozzola, Elena, and Bozzola, Mauro
- Published
- 2022
- Full Text
- View/download PDF
31. Early recognition of child abuse through screening indicators at the emergency department: experience of a tertiary urban pediatric hospital
- Author
-
Offidani, Caterina, Villani, Alberto, Reale, Antonino, Marchili, Maria Rosaria, Aufiero, Lelia Rotondi, Moras, Patrizio, Lodise, Maria, Raucci, Umberto, Barbieri, Maria Antonietta, and Raponi, Massimiliano
- Published
- 2022
- Full Text
- View/download PDF
32. Correction: Inter-society consensus for the use of inhaled corticosteroids in infants, children and adolescents with airway diseases
- Author
-
Duse, Marzia, Santamaria, Francesca, Verga, Maria Carmen, Bergamini, Marcello, Simeone, Giovanni, Leonardi, Lucia, Tezza, Giovanna, Bianchi, Annamaria, Capuano, Annalisa, Cardinale, Fabio, Cerimoniale, Giovanni, Landi, Massimo, Malventano, Monica, Tosca, Mariangela, Varricchio, Attilio, Zicari, Anna Maria, Alfaro, Carlo, Barberi, Salvatore, Becherucci, Paolo, Bernardini, Roberto, Biasci, Paolo, Caffarelli, Carlo, Caldarelli, Valeria, Capristo, Carlo, Castronuovo, Serenella, Chiappini, Elena, Cutrera, Renato, De Castro, Giovanna, De Franciscis, Luca, Decimo, Fabio, Iacono, Iride Dello, Diaferio, Lucia, Di Cicco, Maria Elisa, Di Mauro, Caterina, Di Mauro, Cristina, Di Mauro, Dora, Di Mauro, Francesco, Di Mauro, Gabriella, Doria, Mattia, Falsaperla, Raffaele, Ferraro, Valentina, Fanos, Vassilios, Galli, Elena, Ghiglioni, Daniele Giovanni, Indinnimeo, Luciana, Kantar, Ahmad, Lamborghini, Adima, Licari, Amelia, Lubrano, Riccardo, Luciani, Stefano, Macrì, Francesco, Marseglia, Gianluigi, Martelli, Alberto Giuseppe, Masini, Luigi, Midulla, Fabio, Minasi, Domenico, Miniello, Vito Leonardo, Del Giudice, Michele Miraglia, Morandini, Sergio Renzo, Nardini, Germana, Nocerino, Agostino, Novembre, Elio, Pajno, Giovanni Battista, Paravati, Francesco, Piacentini, Giorgio, Piersantelli, Cristina, Pozzobon, Gabriella, Ricci, Giampaolo, Spanevello, Valter, Turra, Renato, Zanconato, Stefania, Borrelli, Melissa, Villani, Alberto, Corsello, Giovanni, Di Mauro, Giuseppe, and Peroni, Diego
- Published
- 2022
- Full Text
- View/download PDF
33. Influenza vaccination coverage in pediatric population in Italy: an analysis of recent trends
- Author
-
D’Ambrosio, Floriana, Lanza, Teresa Eleonora, Messina, Rosaria, Villani, Leonardo, Pezzullo, Angelo Maria, Ricciardi, Walter, Rosano, Aldo, and Cadeddu, Chiara
- Published
- 2022
- Full Text
- View/download PDF
34. Alert sign and symptoms for the early diagnosis of pulmonary tuberculosis: analysis of patients followed by a tertiary pediatric hospital
- Author
-
Farina, Elisa, D’Amore, Carmen, Lancella, Laura, Boccuzzi, Elena, Ciofi degli Atti, Marta Luisa, Reale, Antonino, Rossi, Paolo, Villani, Alberto, Raponi, Massimiliano, and Raucci, Umberto
- Published
- 2022
- Full Text
- View/download PDF
35. Children at risk of domestic accidents when are locked up at home: the other side of COVID-19 outbreak lockdown
- Author
-
Ferro, Valentina, Nacca, Raffaella, Pisani, Mara, Cristaldi, Sebastian, Faa, Maria Francesca, Supino, Maria Chiara, Raucci, Umberto, Reale, Antonino, Atti, Marta Ciofi Degli, Raponi, Massimiliano, Villani, Alberto, and Musolino, Anna Maria
- Published
- 2022
- Full Text
- View/download PDF
36. The pandemic within the pandemic: the surge of neuropsychological disorders in Italian children during the COVID-19 era
- Author
-
Bozzola, Elena, Ferrara, Pietro, Spina, Giulia, Villani, Alberto, Roversi, Marco, Raponi, Massimiliano, Corsello, Giovanni, and Staiano, Annamaria
- Published
- 2022
- Full Text
- View/download PDF
37. Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement
- Author
-
Lanari, Marcello, Venturini, Elisabetta, Pierantoni, Luca, Stera, Giacomo, Castelli Gattinara, Guido, Esposito, Susanna Maria Roberta, Favilli, Silvia, Franzoni, Emilio, Fusco, Eleonora, Lionetti, Paolo, Maffeis, Claudio, Marseglia, Gianluigi, Massella, Laura, Midulla, Fabio, Zanobini, Alberto, Zecca, Marco, Villani, Alberto, Staiano, Annamaria, and Galli, Luisa
- Published
- 2022
- Full Text
- View/download PDF
38. Current clinical management of constitutional delay of growth and puberty
- Author
-
Gaudino, Rossella, De Filippo, Gianpaolo, Bozzola, Elena, Gasparri, Manuela, Bozzola, Mauro, Villani, Alberto, and Radetti, Giorgio
- Published
- 2022
- Full Text
- View/download PDF
39. Influenza vaccination coverage in pediatric population in Italy: an analysis of recent trends
- Author
-
Floriana D’Ambrosio, Teresa Eleonora Lanza, Rosaria Messina, Leonardo Villani, Angelo Maria Pezzullo, Walter Ricciardi, Aldo Rosano, and Chiara Cadeddu
- Subjects
Influenza ,Vaccination ,Italy ,Coverage ,Children ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Influenza is a major cause of morbidity, mortality and exacerbation of extant chronic disease worldwide. Influenza vaccination is thus fundamental to reduce the burden of disease. In this study, we describe the trend of influenza vaccination coverage in the seasons 2010/11–2020/21 among children aged
- Published
- 2022
- Full Text
- View/download PDF
40. Incidental pineal gland cyst in girls with early onset of puberty
- Author
-
Gianpaolo De Filippo, Rossella Gaudino, Valeria Calcaterra, Alberto Villani, Elena Bozzola, and Mauro Bozzola
- Subjects
Pineal gland ,Incidentaloma ,Precocious puberty ,Central early puberty ,Magnetic resonance imaging ,Pediatrics ,RJ1-570 - Abstract
Abstract Background The causes of an early onset of puberty are still not clearly defined and may vary from subject to subject. In girls, even if 90% of early puberty is idiopathic, magnetic resonance imaging (MRI) of the brain is performed to exclude secondary causes of precocious puberty, in particular pathological lesions as hypothalamic tumours (hamartoma). In some cases, other intracranial lesions are considered as incidental findings. Aim of the study is evaluating the prevalence of abnormal intracranial lesions detected by brain magnetic resonance imaging MRI with particular focus on the prevalence of pineal gland cysts in the diagnostic work-up of girls with central precocious puberty (CPP) as onset before 8 years and central early puberty (CEP) as onset before 10 years. Material and methods MRI data of girls referred from January 2010 to December 2015 to the Pediatric Endocrinology Unit of University of Pavia for early onset of breast development were collected. Results We collected 123 MRI data of girls referred to the Pediatric Endocrinology Unit of University of Pavia for early onset of breast development in the study period. Out of them, 25 (20.3%) had cerebral abnormalities and 15 (12.2%) had pineal gland cysts. No significant differences were noted in auxological, ultrasound and hormonal parameters at diagnosis among girls with or without pineal cysts. Patients have been observed for at least three years after the discontinuation of therapy. None of our patients had an unfavorable evolution. Conclusions Although pineal cysts seem to be not involved in the onset of puberty, the relevance of the finding remains controversial. Our study wants to provide further insight into the incidence of pineal cysts in pubertal advances. Of note, pineal cysts are often asymptomatic and do not evolve over time.
- Published
- 2022
- Full Text
- View/download PDF
41. Current clinical management of constitutional delay of growth and puberty
- Author
-
Rossella Gaudino, Gianpaolo De Filippo, Elena Bozzola, Manuela Gasparri, Mauro Bozzola, Alberto Villani, and Giorgio Radetti
- Subjects
Puberty ,Delayed puberty ,Bone age ,Growth ,Constitutional delay of growth and puberty ,Hypogonadotropic hypogonadism ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Constitutional delay of growth and puberty (CDGP) is classified as the most frequent cause of delayed puberty (DP). Finding out the etiology of DP during first evaluation may be a challenge. In details, pediatricians often cannot differentiate CDGP from permanent hypogonadotropic hypogonadism (PHH), with definitive diagnosis of PHH awaiting lack of puberty by age 18 yr. Neverthless, the ability in providing a precise and tempestive diagnosis has important clinical consequences. Main text A growth failure in adolescents with CDGP may occur until the onset of puberty; after that the growth rate increases with rapidity. Bone age is typically delayed. CDGP is generally a diagnosis of exclusion. Nevertheless, other causes of DP must be evaluated. A family history including timing of puberty in the mother and in the father as well as physical examination may givee information on the cause of DP. Patients with transient delay in hypothalamic-pituitary-gonadal axis maturation due to associated conditions, such as celiac disease, inflammatory bowel diseases, kidney insufficiency and anorexia nervosa, may experience a functional hypogonadotropic hypogonadism. PHH revealing testosterone or estradiol low serum values and reduced FSH and LH levels may be connected to abnormalities in the central nervous system. So, magnetic resonance imaging is required in order to exclude either morphological alterations or neoplasia. If the adolescent with CDGP meets psychological difficulties, treatment is recommended. Conclusion Even if CDGP is considered a variant of normal growth rather than a disease, short stature and retarded sexual development may led to psychological problems, sometimes associated to a poor academic performance. A prompt and precise diagnosis has an important clinical outcome. Aim of this mini-review is throwing light on management of patients with CDGP, emphasizing the adolescent diagnosis and trying to answer all questions from paediatricians.
- Published
- 2022
- Full Text
- View/download PDF
42. Early recognition of child abuse through screening indicators at the emergency department: experience of a tertiary urban pediatric hospital
- Author
-
Caterina Offidani, Alberto Villani, Antonino Reale, Maria Rosaria Marchili, Lelia Rotondi Aufiero, Patrizio Moras, Maria Lodise, Umberto Raucci, Maria Antonietta Barbieri, and Massimiliano Raponi
- Subjects
Child abuse ,Neglect ,Maltreatment ,Sexual abuse ,Screening ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Emergency Departments play a pivotal role in detecting cases of child abuse. Despite the efforts made in the past decades on the need for a screening method for the early detection of abuse victims, a unique instrument shared by the international scientific community has not been made. These instruments should be able to help recognizing whether it is necessary to further investigate the child’s condition. The aim of the study is to illustrate the screening indicators in use since 2010 in the Emergency Department of the Bambino Gesù Children’s Hospital to early recognise the victims of abuse and the modifying process of the screening tool undertaken over the years. Methods We retrospectively analyzed the process that led to the editing of the indicators of child abuse in use nowadays at the Bambino Gesù Children's Hospital. We codified three clinical pathways to apply in case of suspected abuse. Furthermore, we investigated the medical records of screening-positive accesses in the Paediatric Emergency Department of the Bambino Gesù Children's Hospital from January 2008 to October 2020. Results An estimation of positive screening, regarding the type of abuse suspected, and the number of accessed in ED was made, resulting in a cohort of 956 patients. In 2010 we created a list of 14 items grouped in three clusters: anamnestic declarations or incongruences, carelessness/neglect and evident lesions at physical examination. Positivity to one of the items allows the actuation of the investigating protocol named as clinical pathway.In 2013, after three years of experience, the criteria were edited to increase specificity. The application of screening led to a median number of 82 suspected cases/year from 2013 to 2020. Conclusion A screening tool is essential and productive for the early recognition of victims of abuse. An in-deep analysis of suspected cases through a standardized method, such as the clinical pathway, allowed reaching the diagnosis in a more accurate and precise manner.
- Published
- 2022
- Full Text
- View/download PDF
43. Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement
- Author
-
Marcello Lanari, Elisabetta Venturini, Luca Pierantoni, Giacomo Stera, Guido Castelli Gattinara, Susanna Maria Roberta Esposito, Silvia Favilli, Emilio Franzoni, Eleonora Fusco, Paolo Lionetti, Claudio Maffeis, Gianluigi Marseglia, Laura Massella, Fabio Midulla, Alberto Zanobini, Marco Zecca, Alberto Villani, Annamaria Staiano, Luisa Galli, and Other Collaborators
- Subjects
Monoclonal antibody ,COVID19 ,Adolescents ,Risk factors ,Pediatrics ,RJ1-570 - Abstract
Abstract The fast diffusion of the SARS-CoV-2 pandemic have called for an equally rapid evolution of the therapeutic options. The Human recombinant monoclonal antibodies (mAbs) have recently been approved by the Food and Drug Administration (FDA) and by the Italian Medicines Agency (AIFA) in subjects aged ≥12 with SARS-CoV-2 infection and specific risk factors. Currently the indications are specific for the use of two different mAbs combination: Bamlanivimab+Etesevimab (produced by Eli Lilly) and Casirivimab+Imdevimab (produced by Regeneron). These drugs have shown favorable effects in adult patients in the initial phase of infection, whereas to date few data are available on their use in children. AIFA criteria derived from the existing literature which reports an increased risk of severe COVID-19 in children with comorbidities. However, the studies analyzing the determinants for progression to severe disease are mainly monocentric, with limited numbers and reporting mostly generic risk categories. Thus, the Italian Society of Pediatrics invited its affiliated Scientific Societies to produce a Consensus document based on the revision of the criteria proposed by AIFA in light of the most recent literature and experts’ agreement. This Consensus tries to detail which patients actually have the risk to develop severe disease, analyzing the most common comorbidities in children, in order to detail the indications for mAbs administration and to guide the clinicians in identifying eligible patients.
- Published
- 2022
- Full Text
- View/download PDF
44. Treatment of children with COVID-19: update of the Italian Society of Pediatric Infectious Diseases position paper
- Author
-
Elisabetta Venturini, Carlotta Montagnani, Silvia Garazzino, Daniele Donà, Luca Pierantoni, Andrea Lo Vecchio, Andrzej Krzysztofiak, Giangiacomo Nicolini, Sonia Bianchini, Luisa Galli, Alberto Villani, Guido Castelli Gattinara, and the Italian SITIP-SIP SARS-Cov-2 pediatric infection study group
- Subjects
Pediatrics ,RJ1-570 - Published
- 2021
- Full Text
- View/download PDF
45. Prevention of recurrent respiratory infections
- Author
-
Elena Chiappini, Francesca Santamaria, Gian Luigi Marseglia, Paola Marchisio, Luisa Galli, Renato Cutrera, Maurizio de Martino, Sara Antonini, Paolo Becherucci, Paolo Biasci, Barbara Bortone, Sergio Bottero, Valeria Caldarelli, Fabio Cardinale, Guido Castelli Gattinara, Martina Ciarcià, Daniele Ciofi, Sofia D’Elios, Giuseppe Di Mauro, Mattia Doria, Luciana Indinnimeo, Andrea Lo Vecchio, Francesco Macrì, Roberto Mattina, Vito Leonardo Miniello, Michele Miraglia del Giudice, Guido Morbin, Marco Antonio Motisi, Andrea Novelli, Anna Teresa Palamara, Maria Laura Panatta, Angela Pasinato, Diego Peroni, Katia Perruccio, Giorgio Piacentini, Massimo Pifferi, Lorenzo Pignataro, Emanuela Sitzia, Chiara Tersigni, Sara Torretta, Irene Trambusti, Giulia Trippella, Diletta Valentini, Sandro Valentini, Attilio Varricchio, Maria Carmen Verga, Claudio Vicini, Marco Zecca, and Alberto Villani
- Subjects
Recurrent respiratory infections ,Children ,Immune system ,Prevention ,Pediatrics ,RJ1-570 - Abstract
Abstract Recurrent respiratory infections (RRIs) are a common clinical condition in children, in fact about 25% of children under 1 year and 6% of children during the first 6 years of life have RRIs. In most cases, infections occur with mild clinical manifestations and the frequency of episodes tends to decrease over time with a complete resolution by 12 years of age. However, RRIs significantly reduce child and family quality of life and lead to significant medical and social costs. Despite the importance of this condition, there is currently no agreed definition of the term RRIs in the literature, especially concerning the frequency and type of infectious episodes to be considered. The aim of this consensus document is to propose an updated definition and provide recommendations with the intent of guiding the physician in the complex process of diagnosis, management and prevention of RRIs.
- Published
- 2021
- Full Text
- View/download PDF
46. Italian consensus on the therapeutic management of uncomplicated acute hematogenous osteomyelitis in children
- Author
-
Andrzej Krzysztofiak, Elena Chiappini, Elisabetta Venturini, Livia Gargiullo, Marco Roversi, Carlotta Montagnani, Elena Bozzola, Sara Chiurchiu, Davide Vecchio, Elio Castagnola, Paolo Tomà, Gian Maria Rossolini, Renato Maria Toniolo, Susanna Esposito, Marco Cirillo, Fabio Cardinale, Andrea Novelli, Giovanni Beltrami, Claudia Tagliabue, Silvio Boero, Daniele Deriu, Sonia Bianchini, Annalisa Grandin, Samantha Bosis, Martina Ciarcià, Daniele Ciofi, Chiara Tersigni, Barbara Bortone, Giulia Trippella, Giangiacomo Nicolini, Andrea Lo Vecchio, Antonietta Giannattasio, Paola Musso, Elena Serrano, Paola Marchisio, Daniele Donà, Silvia Garazzino, Luca Pierantoni, Teresa Mazzone, Paola Bernaschi, Alessandra Ferrari, Guido Castelli Gattinara, Luisa Galli, and Alberto Villani
- Subjects
Paediatric infectious diseases ,Paediatric osteomyelitis ,Bone infections ,Antibiotic therapy ,Children ,Paediatrics ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Acute hematogenous osteomyelitis (AHOM) is an insidious infection of the bone that more frequently affects young males. The etiology, mainly bacterial, is often related to the patient’s age, but it is frequently missed, owing to the low sensitivity of microbiological cultures. Thus, the evaluation of inflammatory biomarkers and imaging usually guide the diagnosis and follow-up of the infection. The antibiotic treatment of uncomplicated AHOM, on the other hand, heavily relies upon the clinician experience, given the current lack of national guidelines for the management of this infection. Methods A systematic review of the studies on the empirical treatment of uncomplicated AHOM in children published in English or Italian between January 1, 2009, and March 31, 2020, indexed on Pubmed or Embase search engines, was carried out. All guidelines and studies reporting on non-bacterial or complicated or post-traumatic osteomyelitis affecting newborns or children older than 18 years or with comorbidities were excluded from the review. All other works were included in this study. Results Out of 4576 articles, 53 were included in the study. Data on different topics was gathered and outlined: bone penetration of antibiotics; choice of intravenous antibiotic therapy according to the isolated or suspected pathogen; choice of oral antibiotic therapy; length of treatment and switch to oral therapy; surgical treatment. Conclusions The therapeutic management of osteomyelitis is still object of controversy. This study reports the first Italian consensus on the management of uncomplicated AHOM in children of pediatric osteomyelitis, based on expert opinions and a vast literature review.
- Published
- 2021
- Full Text
- View/download PDF
47. Acute toxic exposures in children: analysis of a three year registry managed by a Pediatric poison control Center in Italy
- Author
-
M. Marano, F. Rossi, L. Ravà, M. Khalil Ramla, M. Pisani, G. Bottari, L. Genuini, G. Zampini, J. Nunziata, A. Reale, M. A. Barbieri, F. Celeani, M. Di Nardo, C. Cecchetti, F. Stoppa, A. Villani, M. Raponi, S. Livadiotti, and G. Pontrelli
- Subjects
Paediatric poisoning ,Intoxication ,Pharmaceuticals ,Emergency department ,Childhood ,Poison control Centre ,Pediatrics ,RJ1-570 - Abstract
Abstract Introduction Acute pediatric poisoning is an emerging health and social problem. The aim of this study is to describe the characteristics of a large pediatric cohort exposed to xenobiotics, through the analysis of a Pediatric Poison Control Center (PPCc) registry. Methods This study, conducted in the Pediatric Hospital Bambino Gesù of Rome, a reference National Pediatric Hospital, collected data of children whose parents or caregivers contacted the PPCc by phone (group “P”), or who presented to the Emergency Department (group “ED”), during the three-year period 2014–2016. Data were prospectively and systematically collected in a pre-set electronic registry. Comparisons among age groups were performed and multivariable logistic regression models used to investigate associations with outcomes (hospital referral for “P”, and hospital admission for “ED”group). Results We collected data of 1611 children on group P and 1075 on group ED. Both groups were exposed to both pharmaceutical and non-pharmaceutical agents. Pharmaceutical agent exposure increased with age and the most common route of exposure was oral. Only 10% among P group were symptomatic children, with gastrointestinal symptoms. Among the ED patients, 30% were symptomatic children mostly with gastrointestinal (55.4%) and neurologic symptoms (23.8%). Intentional exposure (abuse substance and suicide attempt), which involved 7.7% of patients, was associated with older age and Hospital admission. Conclusions Our study describes the characteristics of xenobiotics exposures in different paediatric age groups, highlighting the impact of both pharmacological and intentional exposure. Furthermore, our study shows the utility of a specific PPCc, either through Phone support or by direct access to ED. PPCc phone counselling could avoid unnecessary access to the ED, a relevant achievement, particularly in the time of a pandemic.
- Published
- 2021
- Full Text
- View/download PDF
48. Pediatric interregional healthcare mobility in Italy
- Author
-
Mario De Curtis, Francesco Bortolan, Davide Diliberto, and Leonardo Villani
- Subjects
Pediatric population ,Healthcare mobility ,Healthcare mobility costs ,Hospitalizations ,Pediatrics ,RJ1-570 - Abstract
Abstract Background The analysis of interregional healthcare mobility represents one of the main criteria for evaluating Regional Healthcare Systems, both in terms of its economic-financial relevance and the quality and satisfaction of the services provided. The aim of the study is to analyze healthcare mobility and its associated cost in Italy in 2019 for all children ≤ 14 years of age. Methods We collected data from the “Rapporto annuale sull’attività di ricovero ospedaliero – Dati SDO 2019” published by the Italian Ministry of Health. These data represent the tool for collecting information relating to all hospitalization services provided in accredited public and private hospitals present throughout the national territory. We collected data for all Italian regions and clustered them in two geographical areas: Center-North regions and South regions (including Sicily and Sardinia). We have analyzed the magnitude of the mobility of children among regions and in particular from the South to the Center-North and the relative cost of this interregional mobility. Results The hospitalization rate of children residing in the South regions was higher than that of children residing in the Center-North regions (13.9% vs 12.3%). Children residing in the South were more frequently treated in other regions than those living in the Center-North (11.9% vs 6.9%). Even considering the high complexity hospitalizations, children living in the South more frequently underwent treatment in other regions (21.3% vs 10.5% of the Center-North). The cost of passive mobility amounts to € 103.9 million for the South regions (15.1% of the total hospitalizations’ expenditure) and the 87.1% of this cost refers to the mobility to the hospitals of Center-North. The cost of healthcare migration from South regions to other South regions was much lower (12.9%, equal to € 13.4 million). Conclusions Healthcare mobility, while affecting all Italian regions, is particularly relevant in the South regions and indicates a lack of pediatric care, which should be strengthened by creating services that are currently not evenly distributed throughout the territory.
- Published
- 2021
- Full Text
- View/download PDF
49. Clinical characteristics of children infected with SARS-CoV-2 in Italy
- Author
-
Isabella Tarissi De Jacobis, Rosa Vona, Camilla Cittadini, Alessandra Marchesi, Laura Cursi, Lucrezia Gambardella, Alberto Villani, and Elisabetta Straface
- Subjects
Sex differences ,COVID-19 ,Inflammation ,Thrombocytosis ,Pediatric population ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Since December 2019 coronavirus disease (COVID-19) emerged in Wuhan and spread rapidly worldwide. Despite the high number of people affected, data on clinical features and prognostic factors in children and adolescents are limited. We propose a retrospective study aimed to evaluate clinical characteristics of children infected with SARS-CoV-2 in Italy. Methods A pediatric population admitted with COVID-19 to Bambino Gesù Children’s Hospital of Rome (Italy) in the period from the end of February to July 2020 has been studied. Medical history, comorbidities, symptoms and laboratory findings were obtained from patients’ electronic medical records. Results In 66 patients (35 males and 31 females) we found that: i) fever and cough were the dominant symptoms, while vomit and convulsions were rare symptoms; and ii) all ages of childhood were susceptible to COVID-19. Furthermore, we found that, compared to females, males with COVID-19, although not significantly, had higher values of inflammatory markers such as C-reactive protein (CRP) and ESR. Conversely, we found that COVID-19 positive females were older than males and required more days of hospitalization. Both males and females COVID-19 positives had procalcitonin values within the normal range and D-Dimer values slightly higher than the normal range. With regard to this latter marker, the value measured in females, although not significant, was higher than that measured in males. Interestingly, the presence of leukopenia was found in both sexes. Conclusions Compared to the adults we found that COVID-19 infection in children is a non-severe inflammatory disease in both males and females. In any case, many detailed studies should be conducted.
- Published
- 2021
- Full Text
- View/download PDF
50. Recommendations for neonatologists and pediatricians working in first level birthing centers on the first communication of genetic disease and malformation syndrome diagnosis: consensus issued by 6 Italian scientific societies and 4 parents’ associations
- Author
-
Gregorio Serra, Luigi Memo, Alessandra Coscia, Mario Giuffré, Ambra Iuculano, Mariano Lanna, Diletta Valentini, Anna Contardi, Sauro Filippeschi, Tiziana Frusca, Fabio Mosca, Luca A. Ramenghi, Corrado Romano, Annalisa Scopinaro, Alberto Villani, Giuseppe Zampino, Giovanni Corsello, and on behalf of their respective Scientific Societies and Parents’ Associations
- Subjects
Genetic disease ,Malformation syndrome ,Communication of diagnosis ,Consensus ,Recommendations ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Genetic diseases are chronic conditions with relevant impact on the lives of patients and their families. In USA and Europe it is estimated a prevalence of 60 million affected subjects, 75% of whom are in developmental age. A significant number of newborns are admitted in the Neonatal Intensive Care Units (NICU) for reasons different from prematurity, although the prevalence of those with genetic diseases is unknown. It is, then, common for the neonatologist to start a diagnostic process on suspicion of a genetic disease or malformation syndrome, or to make and communicate these diagnoses. Many surveys showed that the degree of parental satisfaction with the methods of communication of diagnosis is low. Poor communication may have short and long-term negative effects on health and psychological and social development of the child and his family. We draw up recommendations on this issue, shared by 6 Italian Scientific Societies and 4 Parents’ Associations, aimed at making the neonatologist’s task easier at the difficult time of communication to parents of a genetic disease/malformation syndrome diagnosis for their child. Methods We used the method of the consensus paper. A multidisciplinary panel of experts was first established, based on the clinical and scientific sharing of the thematic area of present recommendations. They were suggested by the Boards of the six Scientific Societies that joined the initiative: Italian Societies of Pediatrics, Neonatology, Human Genetics, Perinatal Medicine, Obstetric and Gynecological Ultrasound and Biophysical Methodologies, and Pediatric Genetic Diseases and Congenital Disabilities. To obtain a deeper and global vision of the communication process, and to reach a better clinical management of patients and their families, representatives of four Parents’ Associations were also recruited: Italian Association of Down People, Cornelia de Lange National Volunteer Association, Italian Federation of Rare Diseases, and Williams Syndrome People Association. They worked from September 2019 to November 2020 to achieve a consensus on the recommendations for the communication of a new diagnosis of genetic disease. Results The consensus of experts drafted a final document defining the recommendations, for the neonatologist and/or the pediatrician working in a fist level birthing center, on the first communication of genetic disease or malformation syndrome diagnosis. Although there is no universal communication technique to make the informative process effective, we tried to identify a few relevant strategic principles that the neonatologist/pediatrician may use in the relationship with the family. We also summarized basic principles and significant aspects relating to the modalities of interaction with families in a table, in order to create an easy tool for the neonatologist to be applied in the daily care practice. We finally obtained an intersociety document, now published on the websites of the Scientific Societies involved. Conclusions The neonatologist/pediatrician is often the first to observe complex syndromic pictures, not always identified before birth, although today more frequently prenatally diagnosed. It is necessary for him to know the aspects of genetic diseases related to communication and bioethics, as well as the biological and clinical ones, which together outline the cornerstones of the multidisciplinary care of these patients. This consensus provide practical recommendations on how to make the first communication of a genetic disease /malformation syndrome diagnosis. The proposed goal is to make easier the informative process, and to implement the best practices in the relationship with the family. A better doctor-patient/family interaction may improve health outcomes of the child and his family, as well as reduce legal disputes with parents and the phenomenon of defensive medicine.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.